Core Viewpoint - WanKai New Materials (万凯新材) is strategically investing in the humanoid robotics sector by collaborating with Lingxin Qiaoshou (灵心巧手) and establishing an industrial fund with Chengkai Fund to explore new material applications in intelligent manufacturing [1][2]. Group 1: Investment and Collaboration - The company has participated as a lead investor in Lingxin Qiaoshou's PRE-A round financing, acquiring an 8.2% equity stake and a board seat [1]. - The investment is aimed at leveraging the company's resources to support Lingxin Qiaoshou's development in the humanoid robotics field, particularly in the Yangtze River Delta region [2]. - WanKai New Materials is currently testing and developing new material products for potential applications in humanoid robots [1][2]. Group 2: Research and Development - The company is focusing on the development of bio-based furan polyester, new heat-resistant copolyester, and PET chemical recycling technology, which are considered forward-looking projects [3]. - There is an emphasis on exploring the application of polyester new materials (such as PETG and modified PET) in collaboration with Lingxin Qiaoshou [2]. - The company is addressing investor inquiries regarding the current R&D stage, technical barriers, and commercialization timelines for its products [3].

声明： 因水平有限，错误不可避免，或有些信息非最及时，欢迎留言指出。本文仅作新材料相关领域介绍，本文不构成任何投资建议！转载请注明来源！ 4月22日，都佰城上海创新中心， 都佰城 与 北京微构工场 开启新一轮"深度协同创新加速模式"，双方以优势互补、协同共赢为出发点， 聚焦微生物 PHA组份改性与纳米分散技术的加速产业化落地。 图源 微构工场 PhaBuilder 添加微信请备注： 姓名+公司+职务 ● 依托院士团队，11万吨生物可降解聚酯橡胶项目一期2025年底或实现量产！ ● 着力发展生物材料！河北沧州印发《沧州市支持生物制造产业发展落实举措》 ● 「华恒生物」营收21.78亿元！主产品市场竞争加剧，探寻生物基材料等领域战略合作？ ● 万凯新材：营业收入172.32亿元，生物基呋喃聚酯项目已开展多次中试 碳源精准配制： 筛选可持续、高转化率的碳源，提升PHA产率与分子量可控性。 发酵工艺优化： 引入在线监测与智能调控，实现温度、pH、溶氧等关键参数的动态优化，显著提高细胞产能。 分离与提纯效率提升： 采用高效离心与膜分离等复合技术组合，确保PHA聚合物回收率与纯度满足改性需求。 组份共聚改性： 通过接枝共 ...